Professional Documents
Culture Documents
Andrea Nieves - Week 3
Andrea Nieves - Week 3
Vaginitis
Pathophysiology
Candida vulvovaginitis occurs when the organism penetrates the mucosal lining of the vagina,
resulting in an inflammatory response. The inflammatory cells are polymorphonuclear cells and
macrophage (2). Bacterial vulvovaginitis can result in a lower concentration of Lactobacillus
acidophilus may lead to overgrowth of Gardnerella vaginalis and other anaerobes.
Treatments options
First line treatment for bacterial vaginosis is metronidazole 500mg orally twice a day for 7 days
or alternative treatment topical metronidazole gel 0.75% one full applicators intravaginally once
a day for 5 days or clindamycin cream 2% intravaginally at bedtime for 7 days. Yeast
vulvovaginitis topical azole: miconazole, clotrimazole or butoconazole or a single dose oral
fluconazole 150mg. Trichomoniasis vaginalis treatment metronidazole 2gm oral once a day or
tinidazole 2 gm oral once a day (1,2). Atrophic vaginitis treatments a nonhormonal vaginal
moisturizers and lubricants, vaginal estrogen therapy if moderate to severe symptoms. (3)
Prognosis
In most cases vaginitis has an excellent outcomes and cure but recurrent vaginal infections can
leads to chronic irritation, excoriations and scarring lead to sexual dysfunction. Many women
see some improvements with the use of intravaginal estrogen, risk factors for atrophic vaginitis
are no vaginal birth, cigarette smoking can cause vasoconstriction that lead to a decrease in
secretions and exacerbates symptoms. (1)
References
1. Hildebrand J, Kansagor A. Vaginitis. Ncbi.nlm.nih.gov.
https://www.ncbi.nlm.nih.gov/books/NBK470302/. Published 2021. Accessed January 29, 2021.